The Canadian government has secured the order specifically to treat patients with auto-immune diseases. Following these discussions, India approved the export of five million tablets of the drug hydroxychloroquine to Canada,” Ng’s office confirmed to the National Post. But in the context of the COVID-19 pandemic, making an order for medication or personal protective equipment is far from a guarantee that it will be received. But Catenaro said the five million pills are earmarked for patients who need it to treat lupus, malaria or rheumatoid arthritis. So they will not be used for clinical trials or to treat COVID-19.

Source: National Post April 17, 2020 19:06 UTC